News
Feb 02, 2026
Key TakeawaysAmyloidosis is a rare disease where abnormal proteins build up in the body, and when it affects the eye, it can cause symptoms ranging from mild…
Feb 02, 2026
Key TakeawaysHereditary transthyretin amyloidosis is a rare life-threatening disease caused by misfolded proteins that clump together and build up in organs…
Feb 02, 2026
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260…
Feb 02, 2026
This thesis of Hendrea Tingen investigates how nuclear imaging can improve the diagnosis, monitoring of disease progression, and evaluation of treatment response in…
Feb 02, 2026
The U.S. Food and Drug Administration (FDA) has lifted a clinical hold on a Phase 3 clinical trial testing the investigational gene-editing therapy, nexiguran…
Feb 01, 2026
Cardiac amyloidosis is an infiltrative cardiomyopathy caused by extracellular deposition of misfolded proteins, most commonly immunoglobulin light chains (AL) or…
Feb 01, 2026
Accurate identification of the amyloid fibril protein is the critical first step in the diagnostic pathway for any patient with amyloidosis.Service Overview …
Feb 01, 2026
Event DetailsMarch is Amyloidosis Awareness Month, dedicated to raising awareness of this rare disease, emphasizing the importance of early diagnosis, and…
Feb 01, 2026
Event DetailsWednesday, February 11, 2026, 5:00 - 6:30 PM ESTThe Door163-07 Baisley Blvd, Jamaica, NYHosted by: Christopher OrtizProgram Topic: Hereditary ATTR (…
Jan 31, 2026
Overview This is a prospective case control study to determine the feasibility and utility of myocardial stiffness assessment by cardiac magnetic resonance…